The infection–microbiome–immunity axis in bladder cancer: mechanistic insights and therapeutic perspectives

Shen Pan, Wanlin Cui, Jiaman Lin, Zhujun Wang, Zhenhua Li, Bitian Liu

Open source

DOI
10.3389/fimmu.2025.1716230
Published
2026-01-12
Container
Frontiers in Immunology
Publisher
Frontiers Media SA
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fimmu.2025.1716230,
  title = {The infection–microbiome–immunity axis in bladder cancer: mechanistic insights and therapeutic perspectives},
  author = {Shen Pan and Wanlin Cui and Jiaman Lin and Zhujun Wang and Zhenhua Li and Bitian Liu},
  year = {2026},
  journal = {Frontiers in Immunology},
  doi = {10.3389/fimmu.2025.1716230},
  url = {https://doi.org/10.3389/fimmu.2025.1716230}
}

RIS

TY  - JOUR
TI  - The infection–microbiome–immunity axis in bladder cancer: mechanistic insights and therapeutic perspectives
AU  - Shen Pan
AU  - Wanlin Cui
AU  - Jiaman Lin
AU  - Zhujun Wang
AU  - Zhenhua Li
AU  - Bitian Liu
PY  - 2026
JO  - Frontiers in Immunology
DO  - 10.3389/fimmu.2025.1716230
UR  - https://doi.org/10.3389/fimmu.2025.1716230
ER  - 

APA

Pan, S., Cui, W., Lin, J., Wang, Z., Li, Z., & Liu, B. (2026). The infection–microbiome–immunity axis in bladder cancer: mechanistic insights and therapeutic perspectives. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2025.1716230

Source records